Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

An increased risk for thromboembolism in cancer patients has been observed in patients with solid tumours, whereas little data exist on malignant lymphoma. We found an overall thromboembolic event incidence of 7.7% in 1038 lymphoma patients treated in our institution, with a statistically significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohren, M, Markmann, I, Jentsch-Ullrich, K, Koenigsmann, M, Lutze, G, Franke, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826296/
https://www.ncbi.nlm.nih.gov/pubmed/15798767
http://dx.doi.org/10.1038/sj.bjc.6602504
Descripción
Sumario:An increased risk for thromboembolism in cancer patients has been observed in patients with solid tumours, whereas little data exist on malignant lymphoma. We found an overall thromboembolic event incidence of 7.7% in 1038 lymphoma patients treated in our institution, with a statistically significantly higher incidence in high-grade than in low-grade lymphoma.

Ejemplares similares